**
Recent research has uncovered startling evidence that fetuses may be exposed to significantly higher levels of harmful PFAS (per- and polyfluoroalkyl substances) than previously understood. An investigation conducted by Mount Sinai researchers analysed umbilical cord blood samples, revealing an extensive array of these so-called “forever chemicals,” which are notorious for their persistence in the environment and potential health risks.
Comprehensive Analysis Reveals a Broader Range of PFAS
Traditionally, testing for PFAS in umbilical cord blood has been limited to a select few compounds, such as PFOA and PFOS. However, the latest study broadened this scope, examining 120 umbilical cord blood samples through a more thorough “non-targeted analysis.” This innovative approach identified 42 different PFAS compounds, far exceeding the previous expectations of only four compounds per sample.
Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and a co-author of the study, emphasised the implications of these findings: “It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.” The research suggests that the exposure of babies to PFAS is far more extensive than earlier studies had indicated.
The Hidden Dangers of PFAS
PFAS encompasses a vast array of around 15,000 chemicals widely used in the manufacturing of water- and stain-resistant products. These substances have been linked to a variety of serious health issues, including cancer, birth defects, and reduced immunity. Dubbed “forever chemicals” due to their inability to naturally decompose, PFAS pose a significant risk to public health, especially for vulnerable populations like infants.
A review of 40 separate studies indicated that PFAS have been detected in all tested umbilical cord blood samples, amounting to over 30,000 individual assessments. Elevated levels of these chemicals in mothers have been correlated with increased infant mortality rates, low birth weights, and obesity in later life stages. Furthermore, prenatal exposure has been associated with a host of long-term health complications, including cancer and cardiovascular issues.
Regulatory Oversight Failing to Keep Pace
The disconcerting findings of the Mount Sinai study highlight the inadequacy of current regulatory measures. The US Environmental Protection Agency (EPA) has been slow to update its testing protocols, typically analysing only 30-40 PFAS compounds in water, despite independent studies identifying thousands of different variants in various environmental samples. A previous analysis by The Guardian revealed that regulatory bodies often underestimate PFAS levels, failing to provide a comprehensive picture of the chemical’s prevalence in the environment.
The Mount Sinai research juxtaposed the results from traditional testing methods with the broader non-targeted analysis, revealing that the latter consistently detected a wider array of harmful compounds. While the EPA has approved a new blood test to identify 53 PFAS compounds, Liu pointed out that 31 of the compounds identified in the Mount Sinai study were not included in the EPA’s tests, signalling a critical gap in oversight.
Implications for Future Research
Although the Mount Sinai study did not directly link higher levels of PFAS to specific health outcomes, the association between elevated PFAS levels in blood and increased health risks is well-established. The blood samples analysed were part of the federal government’s Home Study, which seeks to track PFAS exposure and its health repercussions over time. Researchers at Mount Sinai intend to explore the potential health implications further, aiming to shed light on this pressing issue.
David Andrews, acting chief science officer of the Environmental Working Group, a non-profit organisation not involved in the study, stated, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The revelations from this new research are deeply concerning, underscoring the urgent need for stronger regulatory frameworks to protect the most vulnerable among us. With rising levels of PFAS in fetal blood, it becomes increasingly vital to address the environmental and public health crises posed by these chemicals. The potential long-term health effects on infants born with a chemical burden cannot be overstated, emphasising the necessity for immediate action to safeguard future generations from the perils of environmental pollution.
